EDVA · Endovia Health Sciences, Inc. · Insider Trading

The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan, and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The options were granted under the Issuer's 2025 Equity Incentive Plan and the exercisability of the options is subject to execution of the Issuer's standard form of Stock Option Agreement. The options are fully vested.

The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested.

TBF Holdings LLC is an entity which the Reporting Person controls.

The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested.

The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested.

SNS Universal Solutions LLC is an entity which the Reporting Person controls.

The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested.

The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested.

The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants shall vest as follows: one third upon completion of the repayment by the Company of the UpTime Investors and the other two thirds vesting quarterly over a two-year period with the first vesting date on October 31, 2025.

The stock options vest as follows: 5,000 are vested, 5,000 vest on March 20, 2026 and 5,000 vest on March 20, 2027, subject in each case to continued services to the Company as of each applicable vesting date.

Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025.

The options are being issued in connection with appointment as the chief financial officer of the Company, pursuant to the 2020 Long-Term Incentive Compensation Plan. 250,000 of the options vested on April 24, 2024, with the remaining options vesting in two equal annual installments beginning on April 24, 2025.

The stock options shall be exercisable for a 3-year period, and shall vest as follows: 75,000 immediately (125,000 already vested) and 50,000 per quarter for the next 8 quarters.

Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025.

The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested.

SNS Universal Solutions LLC is an entity which the Reporting Person controls.

The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested.

Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025.

SNS Universal Solutions LLC is an entity which the Reporting Person controls.

The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested.

Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025.

The amount beneficially owned will not reconcile to prior Form 4s due to a scriveners error.

The options were issued in connection with serving as a director on SBEV's board, pursuant to the 2020 Long-Term Incentive Compensation Plan. The options are subject to the following vesting schedule: (i) 200,000 shares vested upon execution of Dr. Paglia's offer letter, and (ii) the remaining 400,000 shares vesting 50,000 per quarter beginning May 23, 2024, and ending February 25, 2026. Should there be a change in control of the Company, the options will all immediately vest.

Dr. Paglia's shares remain subject to termination in the event Dr. Paglia chooses to resign during the first 90 days of his tenure.

The expiration date of the options is fixed at 2/26/2034 and is unaffected whether or not Dr. Paglia is engaged with the Company.

The options are being issued in connection with serving as the chief financial officer of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 166,500 of the options vested on May 2, 2023 and 55,500 options will vest on May 2, 2024.

The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 1st day of each month starting June 2023 until January 2024 and 10,416 options will vest on the 1st day of each month starting February 2024 until May 2024.

The Stock Options are issued to SNS Universal Solutions, LLC of which Frederick William Caple is the principle.

The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024.

The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024.

The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024.

One-fourth of the Options vested on May 2, 2022. One-fourth of the Options will vest on May 2, 2023, May 2, 2024, and May 2, 2025.

The options were issued in connection with serving as the interim chief financial officer of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. All 35,000 options vested on May 2, 2022.

Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022.

Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022.

Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022.

Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022.

One-third of the Options vested immediately, one-third of the Options vested on May 15, 2021, and one-third of the Options vest on May 15, 2022.

Not applicable

Not applicable